EDGAR Filing Documents for 0001193125-17-220269

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-220269

Filing Date

2017-07-03

Accepted

2017-06-30 17:37:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d407803ds3.htm	S-3	437689
2	EX-4.4	d407803dex44.htm	EX-4.4	285858
3	EX-4.6	d407803dex46.htm	EX-4.6	115654
4	EX-4.7	d407803dex47.htm	EX-4.7	120429
5	EX-4.8	d407803dex48.htm	EX-4.8	107695
6	EX-5.1	d407803dex51.htm	EX-5.1	27755
7	EX-23.1	d407803dex231.htm	EX-23.1	1939
8	GRAPHIC	g407803407803cm_188.gif	GRAPHIC	1047
9	GRAPHIC	g407803g18h70.jpg	GRAPHIC	43482
	Complete submission text file	0001193125-17-220269.txt		1159657

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005

Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631

Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)